1887

Chapter 57 : Transmissible Spongiform Encephalopathies

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Transmissible Spongiform Encephalopathies, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815981/9781555814250_Chap57-1.gif /docserver/preview/fulltext/10.1128/9781555815981/9781555814250_Chap57-2.gif

Abstract:

Prion diseases, also termed transmissible spongiform encephalopathies (TSEs), are inevitably fatal neurodegenerative conditions which affect humans and a wide variety of animals. The most common form of prion disease in humans is sporadic Creutzfeldt-Jakob disease (sCJD). Human studies also point to a possible role for members of the classical complement cascade in prion pathogenesis; however, their precise role in prion disease is unknown. The majority of cases were caused by implantation of dura mater and injection of pituitary growth hormone. There is uncertainty surrounding the danger of transmission to humans represented by chronic wasting disease. In fact, even transmissibility of bovine spongiform encephalopathy (BSE) to humans relies on circumstantial evidence. Recent advances in neuroimaging, and especially in magnetic resonance imaging (MRI), have revealed that different human prion diseases have specific patterns. Tissue should be fixed in formalin for histologic assessment and snap-frozen for Western blotting. Western blotting of digested PrP reveals three distinct bands, corresponding to di-, mono-, and unglycosylated forms. Depending on the exact conditions under which the protease digestion and the Western blotting procedure are performed, between three and six different PrP types can be distinguished. The fact that the PrP types found in variant CJD (vCJD) patients and in BSE-diseased cattle are identical is one of the main arguments supporting the theory that BSE prions are responsible for the vCJD epidemic in humans.

Citation: Aguzzi A. 2009. Transmissible Spongiform Encephalopathies, p 1307-1324. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch57

Key Concept Ranking

Fourier Transform Infrared Spectroscopy
0.4094108
0.4094108
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Model for prion strain propagation and detection. PrP (cube) exists in equilibrium with a misfolded monomeric isoform (cross). The latter can assemble into structurally heterogeneous yet highly ordered aggregated forms (upper versus lower assemblies) which replicate differentially in select cell lines. A panel of such lines, as provided by Mahal and colleagues, may form the basis for classifying prions. When stained with luminescent conjugated thiophene polymers, PrP aggregates stemming from distinct prion strains fluoresce in different colors.

Citation: Aguzzi A. 2009. Transmissible Spongiform Encephalopathies, p 1307-1324. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch57
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

Models for the conformational conversion of PrP into PrP. (A) The “refolding” or template assistance model postulates an interaction between exogenously introduced PrP and endogenous PrP, which is induced to transform itself into further PrP. A high energy barrier may prevent spontaneous conversion of PrP into PrP. (B) The “seeding” or nucleation-polymerization model proposes that PrP and PrP are in a reversible thermodynamic equilibrium. Only if several monomeric PrP molecules are mounted into a highly ordered seed can further monomeric PrP be recruited and eventually aggregate to amyloid. Within such a crystal-like seed, PrP becomes stabilized. Fragmentation of PrP aggregates increases the number of nuclei, which can recruit further PrP and thus results in apparent replication of the agent.

Citation: Aguzzi A. 2009. Transmissible Spongiform Encephalopathies, p 1307-1324. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch57
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3
FIGURE 3

Western blot analysis of PrP. The currently most popular classification schemes for CJD ( ) reliably discriminate PrP types based on the mobility of the unglycosylated band of PrP and the signal intensity of di-, mono-, and unglycosylated forms of PrP. One scheme ( ) differentiates four principal PrP types (1 to 4) ( ). Three principal PrP types (1, 2a, and 2b) are proposed in the second scheme ( ). MM, homozygous methionine; MV, heterozygous methionine valine; VV, homozygous valine.

Citation: Aguzzi A. 2009. Transmissible Spongiform Encephalopathies, p 1307-1324. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch57
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555815981.ch57
1. Aguzzi, A. 1996. Between cows and monkeys. Nature 381:734.
2. Aguzzi, A. 2000. Prion diseases, blood and the immune system: concerns and reality. Haematologica 85:310.
3. Aguzzi, A. 2004. Understanding the diversity of prions. Nat. Cell. Biol. 6:290292.
4. Aguzzi, A.,, and C. Haass. 2003. Games played by rogue proteins in prion disorders and Alzheimer’s disease. Science 302:814818.
5. Aguzzi, A.,, I. Hegyi,, M. Peltola, and, M. Glatzel. 2000, posting date. Rapport des activitées 1996–1999. Hôpital universitaire de Zurich. Département de pathologie. Institut de neuropathologie. Centre nationale de référence pour les prionoses (NRPE).
6. Aguzzi, A.,, and M. Heikenwalder. 2003. Prion diseases: cannibals and garbage piles. Nature 423:127129.
7. Aguzzi, A.,, and M. Heikenwalder. 2005. Prions, cytokines, and chemokines: a meeting in lymphoid organs. Immunity 22:145154.
8. Aguzzi, A.,, F. Montrasio, and, P. S. Kaeser. 2001. Prions: health scare and biological challenge. Nat. Rev. Mol. Cell. Biol. 2:118126.
9. Aguzzi, A.,, and M. Polymenidou. 2004. Mammalian prion biology. One century of evolving concepts. Cell 116:313327.
10. Aguzzi, A.,, and A. J. Raeber. 1998. Transgenic models of neurodegeneration. Neurodegeneration: of (transgenic) mice and men. Brain Pathol. 8:695697.
11. Aguzzi, A.,, and C. Weissmann. 1997. Prion research: the next frontiers. Nature 389:795798.
12. Aguzzi, A.,, and C. Weissmann. 1996. Sleepless in Bologna: transmission of fatal familial insomnia. Trends Microbiol. 4:129131.
13. Aguzzi, A.,, and C. Weissmann. 1998. Spongiform encephalopathies. The prion’s perplexing persistence. Nature 392:763764.
14. Aguzzi, A.,, and C. Weissmann. 1996. Spongiform encephalopathies: a suspicious signature. Nature 383:666667.
15. Alperovitch, A.,, I. Zerr,, M. Pocchiari,, E. Mitrova,, J. de Pedro Cuesta,, I. Hegyi,, S. Collins,, H. Kretzschmar,, C. van Duijn, and, R. G. Will. 1999. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 353:16731674. (Letter.)
16. Alpers, M. 1988. Epidemiology and clinical aspects of kuru, p. 451–465. In S. B. Prusiner and, M. P. McKinley (ed.), Prions–Novel Infectious Pathogens Causing Scrapie and Creutzfeldt-Jakob Disease. Academic Press, Orlando, FL.
17. Andrews, N. J.,, C. P. Farrington,, H. J. Ward,, S. N. Cousens,, P. G. Smith,, A. M. Molesworth,, R. S. Knight,, J. W. Ironside, and, R. G. Will. 2003. Deaths from variant Creutzfeldt-Jakob disease in the UK. Lancet 361:751752.
18. Aucouturier, P.,, F. Geissmann,, D. Damotte,, G. P. Saborio,, H. C. Meeker,, R. Kascsak,, R. I. Carp, and, T. Wisniewski. 2001. Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie. J. Clin. Invest. 108:703708.
19. Barmada, S.,, P. Piccardo,, K. Yamaguchi,, B. Ghetti, and, D. A. Harris. 2004. GFP-tagged prion protein is correctly localized and functionally active in the brains of transgenic mice. Neurobiol. Dis. 16:527537.
20. Barmada, S. J.,, and D. A. Harris. 2005. Visualization of prion infection in transgenic mice expressing green fluorescent protein-tagged prion protein. J. Neurosci. 25:58245832.
21. Bartz, J. C.,, M. L. Kramer,, M. H. Sheehan,, J. A. L. Hutter,, J. I. Ayers,, R. A. Bessen, and, A. E. Kincaid. 2007. Prion interference is due to a reduction in strain-specific PrPSc levels. J. Virol. 81:689697.
22. Baumann, F.,, M. Tolnay,, C. Brabeck,, J. Pahnke,, U. Kloz,, H. H. Niemann,, M. Heikenwalder,, T. Rulicke,, A. Burkle, and, A. Aguzzi. 2007. Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J. 26:538547.
23. Beekes, M.,, E. Baldauf, and, H. Diringer. 1996. Sequential appearance and accumulation of pathognomonic markers in the central nervous system of hamsters orally infected with scrapie. J. Gen. Virol. 77:19251934.
24. Bessen, R. A.,, and R. F. Marsh. 1992. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J. Virol. 66:20962101.
25. Bessen, R. A.,, and R. F. Marsh. 1994. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J. Virol. 68:78597868.
26. Blanquet-Grossard, F.,, N. M. Thielens,, C. Vendrely,, M. Jamin, and, G. J. Arlaud. 2005. Complement protein C1q recognizes a conformationally modified form of the prion protein. Biochemistry 44:43494356.
27. Blättler, T.,, S. Brandner,, A. J. Raeber,, M. A. Klein,, T. Voigtländer,, C. Weissmann, and, A. Aguzzi. 1997. PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature 389:6973.
28. Borchelt, D. R.,, M. Scott,, A. Taraboulos,, N. Stahl, and, S. B. Prusiner. 1990. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J. Cell. Biol. 110:743752.
29. Brandner, S.,, S. Isenmann,, A. Raeber,, M. Fischer,, A. Sailer,, Y. Kobayashi,, S. Marino,, C. Weissmann, and, A. Aguzzi. 1996. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379:339343.
30. Brown, K. L.,, K. Stewart,, D. L. Ritchie,, N. A. Mabbott,, A. Williams,, H. Fraser,, W. I. Morrison, and, M. E. Bruce. 1999. Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nat. Med. 5:13081312.
31. Brown, P. 1992. The phenotypic expression of different mutations in transmissible human spongiform encephalopathy. Rev. Neurol. (Paris) 148:317327.
32. Brown, P.,, F. Cathala,, R. F. Raubertas,, D. C. Gajdusek, and, P. Castaigne. 1987. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology 37:895904.
33. Brown, P.,, M. Preece,, J. P. Brandel,, T. Sato,, L. McShane,, I. Zerr,, A. Fletcher,, R. G. Will,, M. Pocchiari,, N. R. Cashman,, J. H. d’Aignaux,, L. Cervenakova,, J. Fradkin,, L. B. Schonberger, and, S. J. Collins. 2000. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 55:10751081.
34. Bruce, M. E.,, P. A. McBride, and, C. F. Farquhar. 1989. Precise targeting of the pathology of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie. Neurosci. Lett. 102:16.
35. Bruce, M. E.,, R. G. Will,, J. W. Ironside,, I. McConnell,, D. Drummond,, A. Suttie,, L. McCardle,, A. Chree,, J. Hope,, C. Birkett,, S. Cousens,, H. Fraser, and, C. J. Bostock. 1997. Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 389:498501.
36. Budka, H.,, A. Aguzzi,, P. Brown,, J. M. Brucher,, O. Bugiani,, F. Gullotta,, M. Haltia,, J. J. Hauw,, J. W. Ironside,, K. Jellinger,, H. A. Kretzschmar,, P. L. Lantos,, C. Masullo,, W. Schlote,, J. Tateishi, and, R. O. Weller. 1995. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol. 5:459466.
37. Büeler, H. R.,, A. Aguzzi,, A. Sailer,, R. A. Greiner,, P. Autenried,, M. Aguet, and, C. Weissmann. 1993. Mice devoid of PrP are resistant to scrapie. Cell 73:13391347.
38. Büeler, H. R.,, M. Fischer,, Y. Lang,, H. Bluethmann,, H. P. Lipp,, S. J. DeArmond,, S. B. Prusiner,, M. Aguet, and, C. Weissmann. 1992. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356:577582.
39. Bukau, B.,, J. Weissman, and, A. Horwich. 2006. Molecular chaperones and protein quality control. Cell 125:443451.
40. Castilla, J.,, P. Saa,, C. Hetz, and, C. Soto. 2005. In vitro generation of infectious scrapie prions. Cell 121:195206.
41. Caughey, B.,, and R. E. Race. 1992. Potent inhibition of scrapie-associated PrP accumulation by congo red. J. Neurochem. 59:768771.
42. Caughey, B. W.,, A. Dong,, K. S. Bhat,, D. Ernst,, S. F. Hayes, and, W. S. Caughey. 1991. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30:76727680.
43. Chazot, G.,, E. Broussolle,, C. Lapras,, T. Blättler,, A. Aguzzi, and, N. Kopp. 1996. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet 347:1181. (Letter.)
44. Chernoff, Y. O.,, S. L. Lindquist,, B. Ono,, S. G. Inge-Vechtomov, and, S. W. Liebman. 1995. Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science 268:880884.
45. Chesebro, B.,, M. Trifilo,, R. Race,, K. Meade-White,, C. Teng,, R. LaCasse,, L. Raymond,, C. Favara,, G. Baron,, S. Priola,, B. Caughey,, E. Masliah, and, M. Oldstone. 2005. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308:14351439.
46. Clarke, M. C.,, and D. A. Haig. 1971. Multiplication of scrapie agent in mouse spleen. Res. Vet. Sci. 12:195197.
47. Collinge, J.,, K. C. Sidle,, J. Meads,, J. Ironside, and, A. F. Hill. 1996. Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383:685690.
48. Collins, P. S.,, V. A. Lawson, and, P. C. Masters. 2004. Transmissible spongiform encephalopathies. Lancet 363:5161.
49. Cousens, S. N.,, R. Harries Jones,, R. Knight,, R. G. Will,, P. G. Smith, and, W. B. Matthews. 1990. Geographical distribution of cases of Creutzfeldt-Jakob disease in England and Wales 1970–84. J. Neurol. Neurosurg. Psychiatry 53:459465.
50. Cuille, J.,, and P. L. Chelle. 1939. Experimental transmission of trembling to the goat. C. R. Seances Acad. Sci. 208:10581160.
51. Denzer, K.,, M. J. Kleijmeer,, H. F. Heijnen,, W. Stoor-vogel, and, H. J. Geuze. 2000. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J. Cell Sci. 113(Pt. 19):33653374.
52. Denzer, K.,, M. van Eijk,, M. J. Kleijmeer,, E. Jakobson,, C. de Groot, and, H. J. Geuze. 2000. Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface. J. Immunol. 165:12591265.
53. Department of Health. 2007, posting date. Monthly Creutzfeldt-Jakob disease statistics. http://www.gnn.gov.uk/environment/fullDetail.asp?ReleaseID=319104&NewsAreaID=2&NavigatedFromDepartment=False.
54. Dickinson, A. G.,, H. Fraser,, V. M. Meikle, and, G. W. Outram. 1972. Competition between different scrapie agents in mice. Nat. New Biol. 237:244245.
55. Dickinson, A. G.,, G. B. Young,, J. T. Stamp, and, C. C. Renwick. 1965. An analysis of natural scrapie in Suffolk sheep. Heredity Edinburgh 20:485503.
56. Drisaldi, B.,, R. S. Stewart,, C. Adles,, L. R. Stewart,, E. Quaglio,, E. Biasini,, L. Fioriti,, R. Chiesa, and, D. A. Harris. 2003. Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J. Biol. Chem. 278:2173221743.
57. Fischer, M.,, T. Rülicke,, A. Raeber,, A. Sailer,, M. Moser,, B. Oesch,, S. Brandner,, A. Aguzzi, and, C. Weissmann. 1996. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15:12551264.
58. Flechsig, E.,, D. Shmerling,, I. Hegyi,, A. J. Raeber,, M. Fischer,, A. Cozzio,, C. von Mering,, A. Aguzzi, and, C. Weissmann. 2000. Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron 27:399408.
59. Forster, R.,, A. E. Mattis,, E. Kremmer,, E. Wolf,, G. Brem, and, M. Lipp. 1996. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87:10371047.
60. Fraser, H.,, and A. G. Dickinson. 1973. Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation. J. Comp. Pathol. 83:2940.
61. Fraser, H.,, and A. G. Dickinson. 1968. The sequential development of the brain lesion of scrapie in three strains of mice. J. Comp. Pathol. 78:301311.
62. Frigg, R.,, M. A. Klein,, I. Hegyi,, R. M. Zinkernagel, and, A. Aguzzi. 1999. Scrapie pathogenesis in subclinically infected B-cell-deficient mice. J. Virol. 73:95849588.
63. Gajdusek, D.,, and V. Zigas. 1959. Clinical, pathological and epidemiological study of an acute progressive degenerative disease of the central nervous system among natives of the eastern highlands of New Guinea. Am. J. Med. 26:442469.
64. Gajdusek, D. C. 1977. Unconventional viruses and the origin and disappearance of kuru. Science 197:943960.
65. Gajdusek, D. C.,, C. J. Gibbs, and, M. Alpers. 1966. Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature 209:794796.
66. Gajdusek, D. C.,, and V. Zigas. 1957. Degenerative disease of the central nervous system in New Guinea—the endemic occurrence of ‘kuru’ in the native population. N. Engl. J. Med. 257:974978.
67. Gambetti, P.,, Q. Kong,, W. Zou,, P. Parchi, and, S. G. Chen. 2003. Sporadic and familial CJD: classification and characterisation. Br. Med. Bull. 66:213239.
68. Glatzel, M.,, E. Abela,, M. Maissen, and, A. Aguzzi. 2003. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N. Engl. J. Med. 349:18121820.
69. Glatzel, M.,, F. L. Heppner,, K. M. Albers, and, A. Aguzzi. 2001. Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron 31:2534.
70. Glatzel, M.,, P. M. Ott,, T. Lindner,, J. O. Gebbers,, A. Gmur,, W. Wuest,, G. Huber,, H. Moch,, M. Podvinec,, B. Stamm, and, A. Aguzzi. 2003. Human prion diseases: epidemiology and integrated risk assessment. Lancet Neurol. 2:757763.
71. Glatzel, M.,, C. Rogivue,, A. Ghani,, J. R. Streffer,, L. Amsler, and, A. Aguzzi. 2002. Incidence of Creutzfeldt-Jakob disease in Switzerland. Lancet 360:139141.
72. Gommerman, J. L.,, and J. L. Browning. 2003. Lymphotoxin/light, lymphoid microenvironments and autoimmune disease. Nat. Rev. Immunol. 3:642655.
73. Gommerman, J. L.,, F. Mackay,, E. Donskoy,, W. Meier,, P. Martin, and, J. L. Browning. 2002. Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway. J. Clin. Invest. 110:13591369.
74. Gordon, W. S. 1946. Advances in veterinary research. Vet. Res. 58:516520.
75. Harder, A.,, K. Jendroska,, F. Kreuz,, T. Wirth,, C. Schafranka,, N. Karnatz,, A. Theallier-Janko,, J. Dreier,, K. Lohan,, D. Emmerich,, J. Cervos-Navarro,, O. Windl,, H. A. Kretzschmar,, P. Nurnberg, and, R. Witkowski. 1999. Novel twelve-generation kindred of fatal familial insomnia from Germany representing the entire spectrum of disease expression. Am. J. Med. Genet. 87:311316.
76. Harries Jones, R.,, R. Knight,, R. G. Will,, S. Cousens,, P. G. Smith, and, W. B. Matthews. 1988. Creutzfeldt-Jakob disease in England and Wales, 1980–1984: a case-control study of potential risk factors. J. Neurol. Neurosurg. Psychiatry 51:11131119.
77. Hegde, R. S.,, J. A. Mastrianni,, M. R. Scott,, K. A. DeFea,, P. Tremblay,, M. Torchia,, S. J. DeArmond,, S. B. Prusiner, and, V. R. Lingappa. 1998. A transmembrane form of the prion protein in neurodegenerative disease. Science 279:827834.
78. Heikenwalder, M.,, N. Zeller,, H. Seeger,, M. Prinz,, P. C. Klohn,, P. Schwarz,, N. H. Ruddle,, C. Weissmann, and, A. Aguzzi. 2005. Chronic lymphocytic inflammation specifies the organ tropism of prions. Science 307:11071110.
79. Heppner, F. L.,, A. D. Christ,, M. A. Klein,, M. Prinz,, M. Fried,, J. P. Kraehenbuhl, and, A. Aguzzi. 2001. Transepithelial prion transport by M cells. Nat. Med. 7:976977.
80. Heppner, F. L.,, C. Musahl,, I. Arrighi,, M. A. Klein,, T. Rulicke,, B. Oesch,, R. M. Zinkernagel,, U. Kalinke, and, A. Aguzzi. 2001. Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science 294:178182.
81. Hill, A. F.,, M. Desbruslais,, S. Joiner,, K. C. Sidle,, I. Gowland,, J. Collinge,, L. J. Doey, and, P. Lantos. 1997. The same prion strain causes vCJD and BSE. Nature 389:448450. (Letter.)
82. Hill, A. F.,, S. Joiner,, J. A. Beck,, T. A. Campbell,, A. Dickinson,, M. Poulter,, J. D. Wadsworth, and, J. Collinge. 2006. Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations. Brain 129:676685.
83. Hill, A. F.,, S. Joiner,, J. Linehan,, M. Desbruslais,, P. L. Lantos, and, J. Collinge. 2000. Species-barrier-independent prion replication in apparently resistant species. Proc. Natl. Acad. Sci. USA 29:1024810253.
84. Hill, A. F.,, S. Joiner,, J. D. Wadsworth,, K. C. Sidle,, J. E. Bell,, H. Budka,, J. W. Ironside, and, J. Collinge. 2003. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126:13331346.
85. Hilton, D. A. 2006. Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease. J. Pathol. 208:134141.
86. Hornemann, S.,, C. Korth,, B. Oesch,, R. Riek,, G. Wider,, K. Wuthrich, and, R. Glockshuber. 1997. Recombinant full-length murine prion protein, mPrP(23-231): purification and spectroscopic characterization. FEBS Lett. 413:277281.
87. Houston, F.,, J. D. Foster,, A. Chong,, N. Hunter, and, C. J. Bostock. 2000. Transmission of BSE by blood transfusion in sheep. Lancet 356:9991000.
88. Hsiao, K.,, H. F. Baker,, T. J. Crow,, M. Poulter,, F. Owen,, J. D. Terwilliger,, D. Westaway,, J. Ott, and, S. B. Prusiner. 1989. Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature 338:342345.
89. Hsiao, K.,, and S. B. Prusiner. 1990. Inherited human prion diseases. Neurology 40:18201827.
90. Hsiao, K. K.,, D. Groth,, M. Scott,, S. L. Yang,, H. Serban,, D. Rapp,, D. Foster,, M. Torchia,, S. J. DeArmond, and, S. B. Prusiner. 1994. Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc. Natl. Acad. Sci. USA 91:91269130.
91. Hsiao, K. K.,, M. Scott,, D. Foster,, D. F. Groth,, S. J. DeArmond, and, S. B. Prusiner. 1990. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250:15871590.
92. Jarrett, J. T.,, and P. T. Lansbury, Jr. 1993. Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie? Cell 73:10551058.
93. Jeffrey, M.,, G. McGovern,, C. M. Goodsir,, K. L. Brown, and, M. E. Bruce. 2000. Sites of prion protein accumulation in scrapie-infected mouse spleen revealed by immunoelectron microscopy. J. Pathol. 191:323332.
94. Kaeser, P. S.,, M. A. Klein,, P. Schwarz, and, A. Aguzzi. 2001. Efficient lymphoreticular prion propagation requires PrPc in stromal and hematopoietic cells. J. Virol. 75:70977106.
95. Kimberley, F. C.,, B. Sivasankar, and, B. Paul Morgan. 2007. Alternative roles for CD59. Mol. Immunol. 44:7381.
96. King, C. Y.,, and R. Diaz-Avalos. 2004. Protein-only transmission of three yeast prion strains. Nature 428:319323.
97. Kirschbaum, W. R. 1924. Zwei eigenartige Erkrankungen des Zentralnervensystems nach Art der spastischen Pseudosklerose (Jakob). Z. Ges. Neurol. Psychiatr. 92:175220.
98. Klein, M. A.,, R. Frigg,, E. Flechsig,, A. J. Raeber,, U. Kalinke,, H. Bluethmann,, F. Bootz,, M. Suter,, R. M. Zinkernagel, and, A. Aguzzi. 1997. A crucial role for B cells in neuroinvasive scrapie. Nature 390:687690.
99. Klein, M. A.,, R. Frigg,, A. J. Raeber,, E. Flechsig,, I. Hegyi,, R. M. Zinkernagel,, C. Weissmann, and, A. Aguzzi. 1998. PrP expression in B lymphocytes is not required for prion neuroinvasion. Nat. Med. 4:14291433.
100. Klein, M. A.,, P. S. Kaeser,, P. Schwarz,, H. Weyd,, I. Xenarios,, R. M. Zinkernagel,, M. C. Carroll,, J. S. Verbeek,, M. Botto,, M. J. Walport,, H. Molina,, U. Kalinke,, H. Acha-Orbea, and, A. Aguzzi. 2001. Complement facilitates early prion pathogenesis. Nat. Med. 7:488492.
101. Klohn, P. C.,, L. Stoltze,, E. Flechsig,, M. Enari, and, C. Weissmann. 2003. A quantitative, highly sensitive cellbased infectivity assay for mouse scrapie prions. Proc. Natl. Acad. Sci. USA 100:1166611671.
102. Knaus, K. J.,, M. Morillas,, W. Swietnicki,, M. Malone,, W. K. Surewicz, and, V. C. Yee. 2001. Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat. Struct. Biol. 8:770774.
103. Kovacs, G. G.,, P. Gasque,, T. Strobel,, E. Lindeck-Pozza,, M. Strohschneider,, J. W. Ironside,, H. Budka, and, M. Guentchev. 2004. Complement activation in human prion disease. Neurobiol. Dis. 15:2128.
104. Kovacs, G. G.,, E. Lindeck-Pozza,, L. Chimelli,, A. Q. Araújo,, A. A. Gabbai,, T. Ströbel,, M. Glatzel,, A. Aguzzi, and, H. Budka. 2004. Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle. Ann. Neurol. 55:121125.
105. Ladogana, A.,, M. Puopolo,, E. A. Croes,, H. Budka,, C. Jarius,, S. Collins,, G. M. Klug,, T. Sutcliffe,, A. Giulivi,, A. Alperovitch,, N. Delasnerie-Laupretre,, J. P. Brandel,, S. Poser,, H. Kretzschmar,, I. Rietveld,, E. Mitrova,, P. Cuesta Jde,, P. Martinez-Martin,, M. Glatzel,, A. Aguzzi,, R. Knight,, H. Ward,, M. Pocchiari,, C. M. van Duijn,, R. G. Will, and, I. Zerr. 2005. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 64:15861591.
106. Lasmezas, C. I.,, J. P. Deslys,, R. Demaimay,, K. T. Adjou,, F. Lamoury,, D. Dormont,, O. Robain,, J. Ironside, and, J. J. Hauw. 1996. BSE transmission to macaques. Nature 381:743744.
107. Leblanc, P.,, S. Alais,, I. Porto-Carreiro,, S. Lehmann,, J. Grassi,, G. Raposo, and, J. L. Darlix. 2006. Retrovirus infection strongly enhances scrapie infectivity release in cell culture. EMBO J. 25:26742685.
108. Legname, G.,, I. V. Baskakov,, H. O. Nguyen,, D. Riesner,, F. E. Cohen,, S. J. DeArmond, and, S. B. Prusiner. 2004. Synthetic mammalian prions. Science 305:673676.
109. Ligios, C.,, C. J. Sigurdson,, C. Santucciu,, G. Carcassola,, G. Manco,, M. Basagni,, C. Maestrale,, M. G. Cancedda,, L. Madau, and, A. Aguzzi. 2005. PrPSc in mammary glands of sheep affected by scrapie and mastitis. Nat. Med. 11:11371138.
110. Llewelyn, C. A.,, P. E. Hewitt,, R. S. Knight,, K. Amar,, S. Cousens,, J. Mackenzie, and, R. G. Will. 2004. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363:417421.
111. Ma, J.,, and S. Lindquist. 2002. Conversion of PrP to a self-perpetuating Pr-PSc-like conformation in the cytosol. Science 298:17851788.
112. Ma, J.,, R. Wollmann, and, S. Lindquist. 2002. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298:17811785.
113. Mabbott, N. A.,, M. E. Bruce,, M. Botto,, M. J. Walport, and, M. B. Pepys. 2001. Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nat. Med. 7:485487.
114. Mabbott, N. A.,, F. Mackay,, F. Minns, and, M. E. Bruce. 2000. Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie. Nat. Med. 6:719720. (Letter.)
115. Mabbott, N. A.,, G. McGovern,, M. Jeffrey, and, M. E. Bruce. 2002. Temporary blockade of the tumor necrosis factor receptor signaling pathway impedes the spread of scrapie to the brain. J. Virol. 76:51315139.
116. Mabbott, N. A.,, J. Young,, I. McConnell, and, M. E. Bruce. 2003. Follicular dendritic cell dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway dramatically reduces scrapie susceptibility. J. Virol. 77:68456854.
117. Mallucci, G.,, A. Dickinson,, J. Linehan,, P. C. Klohn,, S. Brandner, and, J. Collinge. 2003. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302:871874.
118. Mallucci, G. R.,, S. Ratte,, E. A. Asante,, J. Linehan,, I. Gowland,, J. G. Jefferys, and, J. Collinge. 2002. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J. 21:202210.
119. Malmgren, R.,, L. Kurland,, B. Mokri, and, J. Kurtzke. 1979. The epidemiology of Creutzfeldt-Jakob disease, p. 93–112. In S. B. Prusiner and, W. J. Hadlow (ed.), Slow Transmissible Diseases of the Nervous System, vol. 1. Academic Press, New York, NY.
120. Manuelidis, L. 1998. Vaccination with an attenuated Creutzfeldt-Jakob disease strain prevents expression of a virulent agent. Proc. Natl. Acad. Sci. USA 95:25202525.
121. Masters, C. L.,, D. C. Gajdusek, and, C. J. Gibbs. 1981. Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Straussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain 104:559588.
122. Masters, C. L.,, and E. P. Richardson. 1978. Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain 101:333344.
123. Mathiason, C. K.,, J. G. Powers,, S. J. Dahmes,, D. A. Osborn,, K. V. Miller,, R. J. Warren,, G. L. Mason,, S. A. Hays,, J. Hayes-Klug,, D. M. Seelig,, M. A. Wild,, L. L. Wolfe,, T. R. Spraker,, M. W. Miller,, C. J. Sigurdson,, G. C. Telling, and, E. A. Hoover. 2006. Infectious prions in the saliva and blood of deer with chronic wasting disease. Science 314:133136.
124. McGovern, G.,, K. L. Brown,, M. E. Bruce, and, M. Jeffrey. 2004. Murine scrapie infection causes an abnormal germinal centre reaction in the spleen. J. Comp. Pathol. 130:181194.
125. Mead, S.,, M. P. Stumpf,, J. Whitfield,, J. A. Beck,, M. Poulter,, T. Campbell,, J. B. Uphill,, D. Goldstein,, M. Alpers,, E. M. Fisher, and, J. Collinge. 2003. Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 300:640643.
126. Medori, R.,, H. J. Tritschler,, A. LeBlanc,, F. Villare,, V. Manetto,, H. Y. Chen,, R. Xue,, S. Leal,, P. Montagna,, P. Cortelli,, P. Tinuper,, P. Avoni,, M. Mochi,, A. Baruzzi,, J. J. Hauw,, J. Ott,, E. Lugaresi,, L. A. Gambetti, and, P. Gambetti. 1992. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N. Engl. J. Med. 326:444449.
127. Meggendorfer, F. 1930. Klinische und genealogische Beobachtungen bei einem Fall von spastischer Pseudo-sklerose Jakobs. Z. Ges. Neurol. Psychiatr. 128:337341.
128. Meier, P.,, N. Genoud,, M. Prinz,, M. Maissen,, T. Rulicke,, A. Zurbriggen,, A. J. Raeber, and, A. Aguzzi. 2003. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease. Cell 113:4960.
129. Meyer-Luehmann, M.,, J. Coomaraswamy,, T. Bolmont,, S. Kaeser,, C. Schaefer,, E. Kilger,, A. Neuenschwander,, D. Abramowski,, P. Frey,, A. L. Jaton,, J. M. Vigouret,, P. Paganetti,, D. M. Walsh,, P. M. Mathews,, J. Ghiso,, M. Staufenbiel,, L. C. Walker, and, M. Jucker. 2006. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313:17811784.
130. Montrasio, F.,, R. Frigg,, M. Glatzel,, M. A. Klein,, F. Mackay,, A. Aguzzi, and, C. Weissmann. 2000. Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288:12571259.
131. Naslavsky, N.,, R. Stein,, A. Yanai,, G. Friedlander, and, A. Taraboulos. 1997. Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J. Biol. Chem. 272:63246331.
132. Notari, S.,, S. Capellari,, A. Giese,, I. Westner,, A. Baruzzi,, B. Ghetti,, P. Gambetti,, H. A. Kretzschmar, and, P. Parchi. 2004. Effects of different experimental conditions on the PrP-Sc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J. Biol. Chem. 279:1679716804.
133. Oidtmann, B.,, D. Simon,, N. Holtkamp,, R. Hoffmann, and, M. Baier. 2003. Identification of cDNAs from Japanese pufferfish (Fugu rubripes) and Atlantic salmon (Salmo salar) coding for homologues to tetrapod prion proteins. FEBS Lett. 538:96100.
134. Padovani, A.,, M. D’Alessandro,, P. Parchi,, P. Cortelli,, G. P. Anzola,, P. Montagna,, L. A. Vignolo,, R. Petraroli,, M. Pocchiari,, E. Lugaresi, and, P. Gambetti. 1998. Fatal familial insomnia in a new Italian kindred. Neurology 51:14911494.
135. Pan, K.-M.,, M. Baldwin,, J. Nguyen,, M. Gasset,, A. Serban,, D. Groth,, I. Mehlhorn,, Z. Huang,, R. J. Fletterick,, F. E. Cohen, and, S. B. Prusiner. 1993. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90:1096210966.
136. Parchi, P.,, R. Castellani,, S. Capellari,, B. Ghetti,, K. Young,, S. G. Chen,, M. Farlow,, D. W. Dickson,, A. A. F. Sima,, J. Q. Trojanowski,, R. B. Petersen, and, P. Gambetti. 1996. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 39:767778.
137. Parchi, P.,, A. Giese,, S. Capellari,, P. Brown,, W. Schulz-Schaeffer,, O. Windl,, I. Zerr,, H. Budka,, N. Kopp,, P. Piccardo,, S. Poser,, A. Rojiani,, N. Streichemberger,, J. Julien,, C. Vital,, B. Ghetti,, P. Gambetti, and, H. Kretzschmar. 1999. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol. 46:224233.
138. Parry, H. B. 1962. Scrapie: a transmissible and hereditary disease of sheep. Heredity 17:75105.
139. Parry, H. B.,, and B. G. Livett. 1973. A new hypothalamic pathway to the median eminence containing neurophysin and its hypertrophy in sheep with natural scrapie. Nature 242:6365.
140. Peden, A. H.,, M. W. Head,, D. L. Ritchie,, J. E. Bell, and, J. W. Ironside. 2004. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364:527529.
141. Peretz, D.,, R. A. Williamson,, G. Legname,, Y. Matsunaga,, J. Vergara,, D. R. Burton,, S. J. DeArmond,, S. B. Prusiner, and, M. R. Scott. 2002. A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron 34:921932.
142. Pocchiari, M.,, S. Schmittinger, and, C. Masullo. 1987. Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters. J. Gen. Virol. 68:219223.
143. Polymenidou, M.,, K. Stoeck,, M. Glatzel,, M. Vey,, A. Bellon, and, A. Aguzzi. 2005. Coexistence of multiple Pr-PSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol. 4:805814.
144. Prinz, M.,, M. Heikenwalder,, T. Junt,, P. Schwarz,, M. Glatzel,, F. L. Heppner,, Y. X. Fu,, M. Lipp, and, A. Aguzzi. 2003. Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature 425:957962.
145. Prinz, M.,, G. Huber,, A. J. Macpherson,, F. L. Heppner,, M. Glatzel,, H. P. Eugster,, N. Wagner, and, A. Aguzzi. 2003. Oral prion infection requires normal numbers of Peyer’s patches but not of enteric lymphocytes. Am. J. Pathol. 162:11031111.
146. Priola, S. A.,, A. Raines, and, W. S. Caughey. 2000. Porphyrin and phthalocyanine antiscrapie compounds. Science 287:15031506.
147. Prusiner, S. B. 1989. Creutzfeldt-Jakob disease and scrapie prions. Alzheimer Dis. Assoc. Disord. 3:5278.
148. Prusiner, S. B. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216:136144.
149. Prusiner, S. B.,, D. F. Groth,, M. P. McKinley,, S. P. Cochran,, K. A. Bowman, and, K. C. Kasper. 1981. Thiocyanate and hydroxyl ions inactivate the scrapie agent. Proc. Natl. Acad. Sci. USA 78:46064610.
150. Prusiner, S. B.,, M. Scott,, D. Foster,, K. M. Pan,, D. Groth,, C. Mirenda,, M. Torchia,, S. L. Yang,, D. Serban,, G. A. Carlson,, P. C. Hoppe,, D. Westaway, and, S. J. DeArmond. 1990. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63:673686.
151. Prusiner, S. B.,, M. R. Scott,, S. J. DeArmond, and, F. E. Cohen. 1998. Prion protein biology. Cell 93:337348.
152. Race, R.,, and B. Chesebro. 1998. Scrapie infectivity found in resistant species. Nature 392:770. (Letter.)
153. Radovanovic, I.,, N. Braun,, O. T. Giger,, K. Mertz,, G. Miele,, M. Prinz,, B. Navarro, and, A. Aguzzi. 2005. Truncated prion protein and Doppel are myelinotoxic in the absence of oligodendrocytic PrPC. J. Neurosci. 25:48794888.
154. Riek, R.,, S. Hornemann,, G. Wider,, M. Billeter,, R. Glockshuber, and, K. Wüthrich. 1996. NMR structure of the mouse prion protein domain Prp(121-231). Nature 382:180182.
155. Riek, R.,, S. Hornemann,, G. Wider,, R. Glockshuber, and, K. Wüthrich. 1997. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett. 413:282288.
156. Rivera-Milla, E.,, C. A. Stuermer, and, E. Malaga-Trillo. 2003. An evolutionary basis for scrapie disease: identification of a fish prion mRNA. Trends Genet. 19:7275.
157. Russmann, H.,, F. Vingerhoets,, J. Miklossy,, P. Maeder,, M. Glatzel,, A. Aguzzi, and, J. Bogousslavsky. 2005. Sporadic Creutzfeldt-Jakob disease: a comparison of pathological findings and diffusion weighted imaging. J. Neurol. 252:338342.
158. Safar, J.,, H. Wille,, V. Itri,, D. Groth,, H. Serban,, M. Torchia,, F. E. Cohen, and, S. B. Prusiner. 1998. Eight prion strains have PrP(Sc) molecules with different conformations. Nat. Med. 4:11571165.
159. Sailer, A.,, H. Büeler,, M. Fischer,, A. Aguzzi, and, C. Weissmann. 1994. No propagation of prions in mice devoid of PrP. Cell 77:967968.
160. Scott, M.,, D. Groth,, D. Foster,, M. Torchia,, S. L. Yang,, S. J. DeArmond, and, S. B. Prusiner. 1993. Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell 73:979988.
161. Scott, M. R.,, R. Will,, J. Ironside,, H. O. Nguyen,, P. Tremblay,, S. J. DeArmond, and, S. B. Prusiner. 1999. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc. Natl. Acad. Sci. USA 96:1513715142.
162. Seeger, H.,, M. Heikenwalder,, N. Zeller,, J. Kranich,, P. Schwarz,, A. Gaspert,, B. Seifert,, G. Miele, and, A. Aguzzi. 2005. Coincident scrapie infection and nephritis lead to urinary prion excretion. Science 310:324326.
163. Shmerling, D.,, I. Hegyi,, M. Fischer,, T. Blattler,, S. Brandner,, J. Gotz,, T. Rulicke,, E. Flechsig,, A. Cozzio,, C. von Mering,, C. Hangartner,, A. Aguzzi, and, C. Weissmann. 1998. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93:203214.
164. Sigurdson, C. J.,, G. Manco,, P. Schwarz,, P. Liberski,, E. A. Hoover,, S. Hornemann,, M. Polymenidou,, M. W. Miller,, M. Glatzel, and, A. Aguzzi. 2006. Strain fidelity of chronic wasting disease upon murine adaptation. J. Virol. 80:1230312311.
165. Sigurdson, C. J.,, K. P. R. Nilsson,, S. Hornemann,, G. Manco,, M. Polymenidou,, P. Schwarz,, M. Leclerc,, P. Hammarström,, K. Wüthrich, and, A. Aguzzi. 18 November 2007. Prion strain discrimination using luminescent conjugated polymers. Nat. Methods doi:10.1038/nmeth1131.
166. Silveira, J. R.,, G. J. Raymond,, A. G. Hughson,, R. E. Race,, V. L. Sim,, S. F. Hayes, and, B. Caughey. 2005. The most infectious prion protein particles. Nature 437:257261.
167. Solforosi, L.,, J. R. Criado,, D. B. McGavern,, S. Wirz,, M. Sanchez-Alavez,, S. Sugama,, L. A. DeGiorgio,, B. T. Volpe,, E. Wiseman,, G. Abalos,, E. Masliah,, D. Gilden,, M. B. Oldstone,, B. Conti, and, R. A. Williamson. 2004. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303:15141516.
168. Sparkes, R. S.,, M. Simon,, V. H. Cohn,, R. E. K. Fournier,, J. Lem,, I. Klisak,, C. Heinzmann,, C. Blatt,, M. Lucero,, T. Mohandas,, S. J. DeArmond,, D. Westaway,, S. B. Prusiner, and, L. P. Weiner. 1986. Assignment of the human and mouse prion protein genes to homologous chromosomes. Proc. Natl. Acad. Sci. USA 83:73587362.
169. Stahl, N.,, M. A. Baldwin,, D. B. Teplow,, L. Hood,, B. W. Gibson,, A. L. Burlingame, and, S. B. Prusiner. 1993. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 32:19912002.
170. Stahl, N.,, D. R. Borchelt,, K. Hsiao, and, S. B. Prusiner. 1987. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51:229240.
171. Stewart, R. S.,, P. Piccardo,, B. Ghetti, and, D. A. Harris. 2005. Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein. J. Neurosci. 25:34693477.
172. Strumbo, B.,, S. Ronchi,, L. C. Bolis, and, T. Simonic. 2001. Molecular cloning of the cDNA coding for Xenopus laevis prion protein. FEBS Lett. 508:170174.
173. Supattapone, S.,, P. Bosque,, T. Muramoto,, H. Wille,, C. Aagaard,, D. Peretz,, H. O. Nguyen,, C. Heinrich,, M. Torchia,, J. Safar,, F. E. Cohen,, S. J. DeArmond,, S. B. Prusiner, and, M. Scott. 1999. Prion protein of 106 residues creates an artificial transmission barrier for prion replication in transgenic mice. Cell 96:869878.
174. Tagliavini, F.,, R. A. McArthur,, B. Canciani,, G. Giaccone,, M. Porro,, M. Bugiani,, P. M. Lievens,, O. Bugiani,, E. Peri,, P. Dall’Ara,, M. Rocchi,, G. Poli,, G. Forloni,, T. Bandiera,, M. Varasi,, A. Suarato,, P. Cassutti,, M. A. Cervini,, J. Lansen,, M. Salmona, and, C. Post. 1997. Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. Science 276:11191122.
175. Tanaka, M.,, P. Chien,, N. Naber,, R. Cooke, and, J. S. Weissman. 2004. Conformational variations in an infectious protein determine prion strain differences. Nature 428:323328.
176. Taraboulos, A.,, K. Jendroska,, D. Serban,, S. L. Yang,, S. J. DeArmond, and, S. B. Prusiner. 1992. Regional mapping of prion proteins in brain. Proc. Natl. Acad. Sci. USA 89:76207624.
177. Tateishi, J.,, K. Doh-ura,, T. Kitamoto,, C. Tanchant,, G. Steinmetz,, J. M. Warter, and, J. W. BoeMard. 1992. Prion protein gene analysis and transmission studies of Creutzfeldt-Jakob disease, p. 129–138. In S. B. Prusiner,, J. Collinge,, J. Powell, and, B. Anderton. (ed.), Prion Diseases of Humans and Animals. Ellis Horwood, London, United Kingdom.
178. Telling, G. C.,, M. Scott,, K. K. Hsiao,, D. Foster,, S. L. Yang,, M. Torchia,, K. C. Sidle,, J. Collinge,, S. J. DeArmond, and, S. B. Prusiner. 1994. Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc. Natl. Acad. Sci. USA 91:99369940.
179. Toyama, B. H.,, M. J. Kelly,, J. D. Gross, and, J. S. Weissman. 2007. The structural basis of yeast prion strain variants. Nature 449:233237.
180. Tribl, G. G.,, G. Strasser,, J. Zeitlhofer,, S. Asenbaum,, C. Jarius,, P. Wessely, and, D. Prayer. 2002. Sequential MRI in a case of Creutzfeldt-Jakob disease. Neuroradiology 44:223226.
181. Trifilo, M. J.,, T. Yajima,, Y. Gu,, N. Dalton,, K. L. Peterson,, R. E. Race,, K. Meade-White,, J. L. Portis,, E. Masliah,, K. U. Knowlton,, B. Chesebro, and, M. B. Oldstone. 2006. Prion-induced amyloid heart disease with high blood infectivity in transgenic mice. Science 313:9497.
182. Tuo, W.,, D. Zhuang,, D. P. Knowles,, W. P. Cheevers,, M. S. Sy, and, K. I. O’Rourke. 2001. Prp-c and Prp-Sc at the fetal-maternal interface. J. Biol. Chem. 276:1822918234.
183. Valleron, A. J.,, P. Y. Boelle,, R. Will, and, J. Y. Cesbron. 2001. Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science 294:17261728.
184. Weissmann, C. 1991. A ‘unified theory’ of prion propagation. Nature 352:679683.
185. Wilesmith, J. W.,, J. B. Ryan,, W. D. Hueston, and, L. J. Hoinville. 1992. Bovine spongiform encephalopathy: epidemiological features 1985 to 1990. Vet. Rec. 130:9094.
186. Will, R. G.,, J. W. Ironside,, M. Zeidler,, S. N. Cousens,, K. Estibeiro,, A. Alperovitch,, S. Poser,, M. Pocchiari,, A. Hofman, and, P. G. Smith. 1996. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921925.
187. Wille, H.,, M. D. Michelitsch,, V. Guenebaut,, S. Supattapone,, A. Serban,, F. E. Cohen,, D. A. Agard, and, S. B. Prusiner. 2002. Structural studies of the scrapie prion protein by electron crystallography. Proc. Natl. Acad. Sci. USA 99:35633568.
188. Windl, O.,, M. Dempster,, J. P. Estibeiro,, R. Lathe,, R. Desilva,, T. Esmonde,, R. Will,, A. Springbett,, T. A. Campbell,, K. C. L. Sidle,, M. S. Palmer, and, J. Collinge. 1996. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom—a systematic analysis of predisposing mutations and allelic variation in the Prnp gene. Hum. Genet. 98:259264.
189. Zeidler, M.,, R. J. Sellar,, D. A. Collie,, R. Knight,, G. Stewart,, M. A. Macleod,, J. W. Ironside,, S. Cousens,, A. C. Colchester,, D. M. Hadley,, R. G. Will, and, A. F. Colchester. 2000. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 355:14121418.
190. Zerr, I.,, M. Pocchiari,, S. Collins,, J. P. Brandel,, J. de Pedro Cuesta,, R. S. Knight,, H. Bernheimer,, F. Cardone,, N. Delasnerie-Laupretre,, N. Cuadrado Corrales,, A. Ladogana,, M. Bodemer,, A. Fletcher,, T. Awan,, A. Ruiz Bremon,, H. Budka,, J. L. Laplanche,, R. G. Will, and, S. Poser. 2000. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 55:811815.

Tables

Generic image for table
TABLE 1

Synopsis of currently used prion strain differentiation assays

Citation: Aguzzi A. 2009. Transmissible Spongiform Encephalopathies, p 1307-1324. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch57
Generic image for table
TABLE 2

Response of the cell panel to four murine prion strains

Citation: Aguzzi A. 2009. Transmissible Spongiform Encephalopathies, p 1307-1324. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch57
Generic image for table
TABLE 3

Human prion diseases: clinical features

Citation: Aguzzi A. 2009. Transmissible Spongiform Encephalopathies, p 1307-1324. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch57
Generic image for table
TABLE 4

Useful supplemental diagnostic tests and specimens for CJD

Citation: Aguzzi A. 2009. Transmissible Spongiform Encephalopathies, p 1307-1324. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch57

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error